| Literature DB >> 9667966 |
D E Bierer1, L G Dubenko, P Zhang, Q Lu, P A Imbach, A W Garofalo, P W Phuan, D M Fort, J Litvak, R E Gerber, B Sloan, J Luo, R Cooper, G M Reaven.
Abstract
Cryptolepine (1) is a rare example of a natural product whose synthesis was reported prior to its isolation from nature. In the previous paper we reported the discovery of cryptolepine's antihyperglycemic properties. As part of a medicinal chemistry program designed to optimize natural product lead structures originating from our ethnobotanical and ethnomedical field research, a series of substituted and heterosubstituted cryptolepine analogues was synthesized. Antihyperglycemic activity was measured in vitro and in an NIDDM mouse model to generate the first structure-bioactivity study about the cryptolepine nucleus.Entities:
Mesh:
Substances:
Year: 1998 PMID: 9667966 DOI: 10.1021/jm970735n
Source DB: PubMed Journal: J Med Chem ISSN: 0022-2623 Impact factor: 7.446